Skip to content

Early Goal Nutrition Therapy Guided by Indirect Calorimetry and Nitrogen Balance Among Critically Ill Patients With Acute Kidney Injury (ENGINE Study)

Early Goal Nutrition Therapy Guided by Indirect Calorimetry and Nitrogen Balance Among Critically Ill Patients With Acute Kidney Injury

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06238674
Acronym
ENGINE
Enrollment
80
Registered
2024-02-02
Start date
2023-03-07
Completion date
2024-03-28
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Critically Ill, Nutrition Disorders

Keywords

Indirect calorimetry, nutrition in acute kidney injury, nutrition in critically ill, nitrogen balance

Brief summary

The goal of this clinical trial is to investigate the effects of nutrition therapy guided by indirect calorimetry and nitrogen balance among critically ill patients with acute kidney injury. The main question it aims to answer whether nutrition therapy guided by indirect calorimetry and nitrogen balance could improve 28 days mortality among critically ill patients with acute kidney injury or not. type of study: clinical trial Participants will be provided enteral or parenteral nutrition after randomization(48-72 days after admissions) with total energy guided by indirect calorimetry measurements and total protein by nitrogen balance with maximum of 1.3 gram per kilogram per day for total of 14 days If there is a comparison group: Researchers will compare with the control groups (nutrition therapy provided by physician using clinical equation of choice or judgements to see if participants were provided with these interventions, their 28 days mortalities would be better

Detailed description

The gold standard for determining energy requirements was recommended by the European Society for Parenteral and Enteral Nutrition (ESPEN) guideline 2021 to use indirect calorimetry(IC), a noninvasive method that allows resting energy expenditure (REE) evaluation based on measurements of oxygen consumption and carbon dioxide production in the exhaled air. As there are no high-quality studies that investigated energy and protein provision in hospitalized patients with acute kidney injury(AKI) or Acute kidney disease (AKD), the recommendations were based on the guidelines and clinical trials from critically ill and polymorbid internal medicine patients because these guidelines and trials included patients with kidney disease. Moreover, there were clinical trials in critically ill patients with severe acute kidney injury found the varying of metabolic states among these patients categorized by IC measurements and no association between calorie intake and mortality outcome. Even though the aforementioned researches did not suggest a link between calorie intake and mortality outcome, no studies were able to meet the energy targets set using indirect calorimetry measurements. This study aims to prove the necessary and benefit of early nutrition therapy after 72 hours of admission with total energy guided by indirect calorimetry measurements aims to meet 70-100% from measurements and total protein guided by urine urea nitrogen balance aims to positive nitrogen balance with maximum of 1.3 gram per kilogram of actual body weight per day for total of 14 days on survival & renal outcomes in critically ill patients with acute kidney injury

Interventions

OTHERindirect calorimetry and nitrogen balance

nutrition therapy with energy guided by indirect calorimetry measurements and total protein guided by nitrogen balance with the maximum of 1.3 g/kg/d , repeated indirect calorimetry if renal replacement therapy was initiated and follow up of urea nitrogen balance after 7 days of intervention to guarantee positive nitrogen balance

indirect calorimetry measurements using the Q-NRG+ device will be conducted and urea nitrogen balance were measured . In the standard care nutrition arm, clinicians will be blinded to indirect calorimetry and urea nitrogen balance measurements

Sponsors

Thammasat University Hospital
CollaboratorOTHER
Wankawee Jeerangsapasuk
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-90 years old * Mechanically ventilated patients with acute kidney injury by Kidney Disease Improving Global Outcomes (KDIGO) criteria * Expected length of ICU stay more than 72 hours and accept to follow the study protocol

Exclusion criteria

* Underlying chronic kidney disease stage 4 or 5 according to KDIGO staging * received renal replacement therapy prior to admission * Post cardiothoracic surgery * Required fraction of inspired oxygen inspired oxygen fraction (FiO2) more than 0.6 * Pregnancy * BMI below 17 or above 35 kg/m2 or very high risk refeeding syndrome * Cirrhosis Child-Pugh score C

Design outcomes

Primary

MeasureTime frameDescription
28 day mortalityup to 28 days after randomization28 day mortality

Secondary

MeasureTime frameDescription
ICU mortalityup to 28 daysICU mortality
Rate of new renal replacement therapyup to 28 daysRate of new renal replacement therapy (times)
Peak serum creatinineup to 28 daysPeak serum creatinine (mg/dl)
Nosocomial infectionup to 28 daysincident of Nosocomial infection (yes or No)
length of ICU stayup to 28 daysDuration of ICU stay (days)
60 day mortalityup to 60 days60 day mortality
Duration of mechanical ventilationup to 28 daysDuration of mechanical ventilation (days)
Treatment separation in energy adequacyup to 28 daysEnergy adequacy % will be calculated as energy delivery (kcal)/ measured energy expenditure (kcal) and expressed as a percentage
adverse eventsup to 28 daysfeeding intolerance, diarrhea (percent)
Blood sugar level and amount of insulin usageup to 28 daysaverage amount of daily amount of insulin usage (unit)

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026